Cragg, Liza
Williams, Siân
van der Molen, Thys
Thomas, Mike
Correia de Sousa, Jaime http://orcid.org/0000-0001-6459-7908
Chavannes, Niels H http://orcid.org/0000-0002-8607-9199
Article History
Received: 15 January 2016
Revised: 2 March 2016
Accepted: 6 June 2016
First Online: 22 September 2016
Competing interests
: MT, JCdeS and NHC are Associate Editors of <i>npj Primary Care Respiratory Medicine</i>, but were not involved in the editorial review of, nor the decision to publish this article. MT in the past 3 years has received speaker’s honoraria for speaking at sponsored meetings or satellite symposia at conferences from the following companies marketing respiratory and allergy products: Aerocrine, Astra Zeneca, Boehringer Inglehiem, GSK, MSD, Teva and Novartis. He has received honoraria for attending advisory panels with Aerocrine, Almirall, Astra Zeneca, BI, Chiesi, GSK, MSD and Novartis. He has received sponsorship to attend international scientific meetings from GSK and Astra Zeneca. He has received funding for research projects from GSK. He is a member of the BTS SIGN Asthma guideline group and the NICE Asthma guideline group. JCdS received sponsorships from, or delivered consultancy services to, Astra Zeneca, Nycomed, GSK, MSD, Novartis, Menarini and Boehringer Ingelheim. LC, NHC and SW declare no conflict of interest.